Tofacitinib Citrate
45-16 Ramsey Road Shirley, NY 11967, USA, Shirley, New York, 11967
About us
Tofacitinib (trade name Xeljanz, formerly tasocitinib, CP-690550) is a drug discovered and developed by Pfizer. It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection.
https://www.bocsci.com/tofacitinib-citrate-cas-540737-29-9-item-461917.html